Pfizer Covid-19 shot 91pct effective in updated data, protective against S African variant


2 Apr 2021, 12:16 pagi

Updated 3 months ago


Pfizer Inc and BioNTech's Covid-19 vaccine is around 91 percent effective in preventing the disease, they said on Thursday, citing updated trial data that included participants inoculated for up to six months.

The shot was also 100 percent effective in preventing illness among trial participants in South Africa, where a new variant called B1351 is dominant, though the number of those participants was relatively small at 800...

All Access Plan


per month
Unlimited access to our articles
Comment on all our stories
Gift articles to your friends
Subscribe Now
You can cancel anytime.
Secure and Encrypted
Student or Senior Citizen? Get a special rateGroup / Institutional / Corporate Plans
Already Subscribed?
Sign In

View Comments (0)